Safran, Jeremy T.Bodaghi, MahdiehSherwin, Nomi K.Wallace, Jessica R.2023-10-062023-10-062023Safran JT, Bodaghi M, Sherwin NK, Wallace JR. Wernicke's encephalopathy in adolescents with anorexia nervosa. Psychiatry Res Case Rep. 2023;2(1):100091. doi:10.1016/j.psycr.2022.100091https://hdl.handle.net/1805/36192Anorexia Nervosa (AN) has always been prevalent in adolescents. During the COVID-19 pandemic, the eating disorder community across the world has noted a sharp increase in adolescent patients with AN and the severity of medical compromise. Rarely seen sequelae have become increasingly more common. This case report describes two previously healthy female adolescents with severe malnutrition due to AN admitted for nutritional stabilization who exhibited paranoid delusions responsive to thiamine and olanzapine. Though neither exhibit the full triad or all the Caine criteria for Wernicke's Encephalopathy (WE), the triad will not present completely in most patients with WE, especially in the pediatric population. Having one symptom of the triad is indicative of WE. Due to the decreased number of clinical criteria for Wernicke's encephalopathy coupled with the lack of typical brain MRI findings found in these patients, we recommend a high index of suspicion for WE and investigation with thiamine. Thiamine supplementation should be standard care in AN with oral supplementation in stable conditions. In the case of refeeding syndromes, preventative parenteral thiamine 100 mg IV qd, and in the case of thiamine deficiency, thiamine 500 mg IV TID.en-USPublisher PolicyAnorexia nervosaWernicke’s encephalopathyAdolescentsThiamineEating disordersArticle